用赖氨酸右旋苯丙胺治疗重度智力障碍中的注意力缺陷/多动障碍：一例报告 - Suppr | 超能文献

Treating Attention-Deficit/Hyperactivity Disorder in Severe Intellectual Disability with Lisdexamfetamine: A Case Report.

作者信息

Araújo Ana, Madeira Nuno, Ventura Fabiana, Morais Sofia, Coroa Manuel, Macedo António, Areias Graça, Borges João

出版信息

J Clin Psychopharmacol. 2021;41(4):490-492. doi: 10.1097/JCP.0000000000001419.

DOI:10.1097/JCP.0000000000001419

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treating Attention-Deficit/Hyperactivity Disorder in Severe Intellectual Disability with Lisdexamfetamine: A Case Report.用赖氨酸右旋苯丙胺治疗重度智力障碍中的注意力缺陷/多动障碍：一例报告

J Clin Psychopharmacol. 2021;41(4):490-492. doi: 10.1097/JCP.0000000000001419.

2

Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder.赖氨酸安非他命甲硫酸盐治疗注意缺陷多动障碍儿童和青少年的综述。

Curr Med Res Opin. 2020 Oct;36(10):1717-1735. doi: 10.1080/03007995.2020.1815002. Epub 2020 Sep 11.

3

Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.一项针对患有注意力缺陷/多动障碍且对哌甲酯反应欠佳的儿童及青少年，比较二甲磺酸赖右苯丙胺和托莫西汀疗效的随机双盲对照试验的功能结局。

Eur Child Adolesc Psychiatry. 2016 Feb;25(2):141-9. doi: 10.1007/s00787-015-0718-0. Epub 2015 May 22.

4

[Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe].[赖氨酸安非他明二甲磺酸盐：德国及欧洲治疗儿童和青少年注意力缺陷/多动障碍的一种选择]

Fortschr Neurol Psychiatr. 2015 Dec;83(12):676-85. doi: 10.1055/s-0041-110441. Epub 2015 Dec 29.

5

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.一项为期 2 年的关于赖氨酸安非他命甲硫酸盐治疗儿童和青少年注意缺陷多动障碍的开放性研究中儿童和青少年的生长和青春期

CNS Drugs. 2018 May;32(5):455-467. doi: 10.1007/s40263-018-0514-8.

6

Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis.扩大对患有注意力缺陷/多动障碍的成年人的公开补贴赖右苯丙胺治疗的可及性：一项中断时间序列分析。

Aust N Z J Psychiatry. 2023 Jul;57(7):1073-1076. doi: 10.1177/00048674231170556. Epub 2023 Apr 25.

7

A new amphetamine oral suspension (Adzenys ER) for ADHD.一种用于治疗注意力缺陷多动障碍（ADHD）的新型苯丙胺口服混悬液（Adzenys ER）。

Med Lett Drugs Ther. 2018 Jun 18;60(1549):e106-e108.

8

Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe.在欧洲，患有注意缺陷多动障碍的儿童、青少年和成年人中，Lisdexamfetamine Dimesylate 的使用模式。

J Child Adolesc Psychopharmacol. 2020 Sep;30(7):439-447. doi: 10.1089/cap.2019.0173. Epub 2020 Apr 21.

9

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.随机、双盲、安慰剂对照急性对照试验：右苯丙胺和哌甲酯缓释剂治疗青少年注意缺陷多动障碍。

CNS Drugs. 2017 Nov;31(11):999-1014. doi: 10.1007/s40263-017-0468-2.

10

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look.2018年英国国家卫生与临床优化研究所（NICE）关于多动症患者药物治疗的更新指南：批判性审视。

BMJ Evid Based Med. 2019 Jun;24(3):99-102. doi: 10.1136/bmjebm-2018-111110. Epub 2018 Dec 10.